We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Verici Dx Plc | LSE:VRCI | London | Ordinary Share | GB00BM8HZD43 | ORD GBP0.001 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.75 | 3.50 | 4.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 3.75 | 3.75 | 3.75 | 15,695 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Business Services, Nec | 1.01M | -8.73M | -0.0360 | -1.11 | 9.1M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 14/1/2025 | 11:01 | UK RNS | Verici Dx PLC Holding(s) in Company |
| 11/10/2024 | 11:22 | ALNC |  Verici Dx delayed coverage determination pushes back Tutivia revenue |
| 11/10/2024 | 06:00 | UK RNS | Verici Dx PLC Update on Local Coverage Determination and Trading |
| 31/7/2024 | 06:00 | UK RNS | Verici Dx PLC Launch of PTRA Assay using Verici Dx's technology |
| 15/7/2024 | 18:36 | ALNC | EARNINGS AND TRADING: Genedrive in FDA boost; Bango revenue rises |
| 15/7/2024 | 06:00 | UK RNS | Verici Dx PLC Half-year Report |
| 11/7/2024 | 13:00 | UK RNS | Verici Dx PLC Notice of Results and Business Update |
| 01/7/2024 | 13:27 | ALNC | IN BRIEF: Verici Dx hails milestone payment in deal with Thermo Fisher |
| 01/7/2024 | 06:00 | UK RNS | Verici Dx PLC Significant milestone re Thermo Fisher agreement |
| 25/6/2024 | 12:27 | UK RNS | Verici Dx PLC Result of AGM |
1 Year Verici Dx Chart |
Intraday Verici Dx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
